July 10, 2025 · Form 4 insider transaction
KOZARICH JOHN W sold 934 shares of Ligand Pharmaceuticals Incorporated at $125.00 per share, a transaction worth $116.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.